Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004616 |
ID: | TCMBANKHE004616 |
药用植物名: | 地黄 |
TCM_ID_id: | 5698 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN001863 | gamma-aminobutyric acid | NCGC00015043-01; gamma Aminobutyric acid; GABA hydrochloride; Piperidinic acid; Spectrum3_001385; NINDS_000616; NSC 27418; 4-Aminobutyric acid hydrochloride; LMFA01100039; gamma-Aminobutanoic acid; gamma-Aminobutyric acid; QPGLUEKHBNOAHG-UHFFFAOYSA-N; NCGC00024546-03; 28805-76-7; Aminalon; Gamarex; Tocris-0344; D00058; Oprea1_584567; DF 468; 3131-86-0; Butyric acid, 4-amino- (7CI,8CI); Immu-G; EU-0100005; NSC32044; 5959-35-3; 4-aminobutyrate hydrochloride; MCULE-3615304273; Chemical Name: .gamma.-Aminobutanoic acid; InChI=1/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7; NCGC00024546-04; SPECTRUM1500678; BUTANOIC ACID,4-AMINO 4-AMINO,BUTYRIC ACID; 0S3LEB8Q58; gamma-Aminobutyric acid-carboxy-14C; Gamastan; BSPBio_002970; PDSP1_001275; Gammalon; Spectrum2_001208; gamma-Aminobuttersaeure; 56-12-2; a-Aminobutyric acid; Gamulin; nchembio.78-comp12; Gaballon; AC1L4OHW; gamma-Aminobutyric acid hydrochloride; PDSP2_001259; SMR000058285; KBio1_000616; 4-NH2-but; Butanoic acid,4-amino-, hydrochloride (1:1); Acide amino-4- butyrique [French]; 4-aminobutyrate; MLS000028505; EINECS 227-724-1; DTXSID50208256; 4-aminobutyric acid; NCGC00024546-01; KBio2_005565; ST5330631; Butanoic acid, amino-; AK498572; CCG-213774; 4-Aminobutyric acid HCl; Reanal; BG00901312; EPA Pesticide Chemical Code 030802; Gamma-Aminobutyric acid (JAN); UNII-0S3LEB8Q58; gamma-Aminobuttersaeure [German]; NSC27418; AC1Q3E7S; to_000021; Spectrum5_001425; Lopac-A-2129; KBioSS_000429; .gamma.-Aminobutanoic acid; A2129_SIGMA; g-Aminobutyric acid; 56-12-2 (Parent); KBio3_002190; SPBio_000996; Gammalon (TN); 4-NH3-but; NCGC00024546-06; NSC51295; CTK5B0181; Gammalone; Piperidic acid; WLN: Z3VQ; SGCUT00121; IDI1_000616; GABA; EINECS 200-258-6; CCRIS 3721; gamma-aminobutyrate; Spectrum_000049; gamma-Aminobutryic acid; KBio2_000429; KBio2_002997; 70582-09-1; omega-aminobutyric acid; Spectrum4_000809; Aminobutanoic acid; 4-aminobutanoic acid,hydrochloride; butanoic acid, 4-amino-; gamma-amino-n-butyric acid; Mielomade; 4-AMINO-BUTYRATE; GAMMA(AMINO)-BUTYRIC ACID HYDROCHLORIDE; Biomol-NT_000230; 4-aminobutanoic acid hydrochloride(1:1); 4-aminobutanoic acid hydrochloride; 4-aminobutanoate; A5835_SIGMA; Lopac0_000005; GAMMA-AMINO-BUTANOIC ACID; CHEBI:16865; 4-amino-butanoic acid; 4-amino-n-butyric acid; Gammar; C00334; Mielogen; Gamma-aminobutyric acid [JAN]; Gammagee; GAMMA(AMINO)-BUTYRIC ACID; NSC45460; AI3-26812; 3-Carboxypropylamine; A7463_SIGMA; Butyric acid, 4-amino-; .gamma.-Aminobutyric acid; SCHEMBL115987; DivK1c_000616; Gammasol; AKOS024400865; Aminobutyric acid; 4-Aminobutanoic acid; KBioGR_001297; Butanoic acid, 4-amino- (9CI) | C4H10ClNO2 | 139.58 g/mol | C(CC(=O)O)CN.Cl |
| TCMBANKIN002310 | aeginetic acid | aegineticacid | C15H24O4 | 268.35 | CC(=CC(=O)O)C=CC1(C(CCCC1(C)O)(C)C)O |
| TCMBANKIN002564 | jionoside b1 | jionoside b 1 | C37H50O20 | 814.78 | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)OCCC5=CC(=C(C=C5)OC)O)O)O)O)O |
| TCMBANKIN004252 | (7R, 8S, 7′R, 8′S)-4, 9, 4′, 9′-tetrahydroxy-3, 3′-dimethoxy-7, 7′-epoxylignan 9-O-β-D-glucopyranoside | C26H34O12 | COC1=C(C=CC(=C1)C2C(C(C(O2)C3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)CO)O | ||
| TCMBANKIN006135 | frehmaglutin B | ||||
| TCMBANKIN007848 | Rehmaionoside C | (E)-4-[(1R,6R)-1-hydroxy-2,2,6-trimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-cyclohexyl]but-3-en-2-one; (E)-4-[(1R,6R)-1-hydroxy-2,2,6-trimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]but-3-en-2-one; (E)-4-[(1R,6R)-1-hydroxy-2,2,6-trimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl]but-3-en-2-one; rehmaionoside c; (E)-4-[(1R,6R)-1-hydroxy-2,2,6-trimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-cyclohexyl]but-3-en-2-one; (E)-4-[(1R,6R)-1-hydroxy-2,2,6-trimethyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]cyclohexyl]but-3-en-2-one | C19H32O8 | 388.5 g/mol | CC(=O)C=CC1(C(CCCC1(C)OC2C(C(C(C(O2)CO)O)O)O)(C)C)O |
| TCMBANKIN011795 | 1-(4-methy-2-furanyl)-2-(5-methyl-5-ethenyl-2-tetrahydrofuranyl)-propan-1-one | C15H20O3 | |||
| TCMBANKIN012734 | trihydroxy-bionone | C13H22O4 | CC(=O)C=CC1(C(C(CCC1(C)O)O)(C)C)O | ||
| TCMBANKIN013357 | myobontioside A | C15H23ClO9 | 382.79 g/mol | C1C(C2C=COC(C2C1(CCl)O)OC3C(C(C(C(O3)CO)O)O)O)O | |
| TCMBANKIN013601 | gardoside methyl ester | C17H24O10 | 388.4 g/mol | COC(=O)C1=COC(C2C1CC(C2=C)O)OC3C(C(C(C(O3)CO)O)O)O | |
| TCMBANKIN013805 | 2-phenylethyl-O-β-D-xylopy-ranosyl-(1→6)-β-D-glucopyranoside | 2-phenylethyl-O-β-D-xylopyranosyl-(1→ 6)-β-D-glucopyranoside | |||
| TCMBANKIN014949 | frehmaglutin C | ||||
| TCMBANKIN017213 | frehmaglutin A | ||||
| TCMBANKIN017309 | 5-deoxylamiol | ||||
| TCMBANKIN018700 | 3,4-dihydroxy-beta-phenethyl-o-beta-d-glucopyranosyl-(1-3)-4-o-cafferoyl-beta-d-glucopyranoside | ||||
| TCMBANKIN018963 | 5-hydroxyoxindole | ZINC02146679; 2H-Indol-2-one, 1,3-dihydro-5-hydroxy-; 5-hydroxy-2-indolinone; 5-hydroxyindolin-2-one; EINECS 222-309-1; 5-hydroxy-1,3-dihydroindol-2-one; 2,3-Dihydro-5-hydroxyindol-2-one; 2-Indolinone, 5-hydroxy-; 3416-18-0 | C8H7NO2 | 149.15 | C1C2=C(C=CC(=C2)O)NC1=O |
| TCMBANKIN019166 | syringic acid-4-O-α-L-rhamnopyranoside | syringicacid-4-O-α-L-rhamnopyranoside | |||
| TCMBANKIN019377 | frehmaglutin E | ||||
| TCMBANKIN022929 | dihydrophaseic acid 4-O-β-D-glucopy-ranoside | ||||
| TCMBANKIN024740 | rhamnopyranosyl vanilloyl | ||||
| TCMBANKIN025049 | 6-O-sec-hydroxyae ginetoyl ajugol | 6-O-sec-hydroxyaeginetoyl ajugol | |||
| TCMBANKIN025588 | rehmamegastigmane | rehmamegastig-mane | |||
| TCMBANKIN025731 | oxyrehmaionoside B | C19H34O9 | 406.5 g/mol | CC(C=CC1(C(C(CCC1(C)OC2C(C(C(C(O2)CO)O)O)O)O)(C)C)O)O | |
| TCMBANKIN027344 | 6β-hydroxy-3-oxo-11,13(18)-oleanadien-28-oicacid | C30H44O4 | CC1(CCC2(CCC3(C(=C2C1)C=CC4C3(CC(C5C4(CCC(=O)C5(C)C)C)O)C)C)C(=O)O)C | ||
| TCMBANKIN029577 | sec-hydroxyaegineticacid | sec-hydroxyaeginetic acid | C15H24O5 | 284.35 g/mol | CC(=CC(=O)O)C=CC1(C(C(CCC1(C)O)O)(C)C)O |
| TCMBANKIN031213 | neo-rehmannioside | ||||
| TCMBANKIN031272 | 3′-O-β-D-glucopyranosyl catalpol | ||||
| TCMBANKIN031465 | rehmaglutosides | C30H46O12 | CC(=CC(=O)OC1CC(C2C1C=COC2OC3C(C(C(C(O3)CO)O)O)O)(C)O)C=CC4(C(CCCC4(C)O)(C)C)O | ||
| TCMBANKIN033489 | mussaenosidicacid | mussaenosidic acid | C16H24O10 | 376.36 g/mol | CC1(CCC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O)O |
| TCMBANKIN034069 | jioglutoside b | C23H34O13 | 518.51 | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C4C(CCC4=C)C(=CO3)C(=O)OC)O)O)O)O)O)O | |
| TCMBANKIN034729 | sculponiside | ||||
| TCMBANKIN035728 | dihydroxy-β-ionone | C13H22O3 | CC(=O)C=CC1(C(CCCC1(C)O)(C)C)O | ||
| TCMBANKIN035918 | 1-methyl-1, 2, 3, 4-tetrahydro-β-carboline-3-carboxylic acid | C13H14N2O2 | CC1C2=C(CC(N1)C(=O)O)C3=CC=CC=C3N2 | ||
| TCMBANKIN035986 | aeginetic acid 5-O-β-D-quinovoside | C21H34O8 | CC1C(C(C(C(O1)OC2(CCCC(C2(C=CC(=CC(=O)O)C)O)(C)C)C)O)O)O | ||
| TCMBANKIN036823 | acteoside | (E)-3-(3,4-dihydroxyphenyl)acrylic acid [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-methylol-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-3-yl] ester; Verbascoside; 22323-52-0; AKOS015965213; Acteoside; [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-, 4-(3-(3,4-dihydroxyphenyl)-2-propenoate), (E)-beta-D-; AIDS030638; AC-6026; BC216166; 61276-17-3; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-3-tetrahydropyranyl] ester; Kusaginin; [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; NSC 603831; (B864379); acteoside ; 27625-92-9; AIDS-030638; C10501; .beta.-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl3-O-(6-deoxy-.alpha.-L-mannopyranosyl)-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]; SCHEMBL18826154 | C29H36O15 | 625 | [C@@]1([H])(OC(=O)\C([H])=C([H])\c2c([H])c([H])c(O[H])c(O[H])c2[H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O3)[C@@]([H])(O[H])[C@]([H])(OC([H])([H] )C([H])([H])c4c([H])c([H])c(O[H])c(O[H])c4[H])O[C@]1([H])C([H])([H])O[H] |
| TCMBANKIN036853 | catalpol | Catalpol; LMPR01020108; beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-; 2415-24-9; Catalpinoside; NCGC00163523-01; beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy- 1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1a-alpha,1b-beta,2-beta,5a-beta,6-beta,6a-alpha))-; Catalposide, des-p-hydroxybenzoyl-; De(p-hydroxybenzoyl)catalposide; (1AS-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl-beta-D-glucopyranoside; C09773; EINECS 219-324-0 | C15H22O10 | 362.33 | C1=COC(C2C1C(C3C2(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O |
| TCMBANKIN037559 | Decaffeoylacteoside | decaffeoy lacteoside | 462.4 g/mol | ||
| TCMBANKIN038483 | 5-Desgalloylstachyurin | BDBM50269547; CHEMBL488110; D07HWB; 5-desgalloylstachyurin | 784.5 g/mol | ||
| TCMBANKIN039338 | rehmapicrogenin | C10H16O3 | 184.23 g/mol | CC1=C(C(CCC1O)(C)C)C(=O)O | |
| TCMBANKIN039940 | Isomartynoside | AIDS112625; isomartynoside; AIDS-112625; .beta.-D-Glucopyranoside, 2-(4-hydroxy-3-methoxyphenyl)ethyl 3-O-(6-deoxy-.alpha.-L-mannopyranosyl)-6-O-[(2E)-3-(3-hydroxy-4-methoxyphenyl)-1-oxo-2-propenyl]- | C31H40O15 | 652.64 | CC1C(C(C(C(O1)OC2C(C(OC(C2O)OCCC3=CC(=C(C=C3)OC)O)COC(=O)C=CC4=CC(=C(C=C4)O)OC)O)O)O)O |
| TCMBANKIN044753 | Leucosceptoside A | leucosceptoside a | 638.61 | ||
| TCMBANKIN045500 | Genameside C | 550.5 g/mol | |||
| TCMBANKIN048374 | Martynoside | [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxy-phenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-3-yl] (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-3-tetrahydropyranyl] ester; [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxy-phenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-3-yl] (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid [(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxy-phenyl)ethoxy]-2-methylol-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-3-yl] ester; martynoside | C31H40O15 | 652.64 | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)OC)CO)OCCC4=CC(=C(C=C4)OC)O)O)O)O)O |
| TCMBANKIN058255 | Tyrosol | NSC 59876; 4-Hydroxybenzeneethanol; P-HYDROXYPHENETHYL ALCOHOL; NSC59876; tyrosol; 56105_FLUKA; Benzeneethanol, 4-hydroxy-; 2-(4-Hydroxyphenyl)ethanol; 4-Hydroxyphenethyl alcohol; 2-(P-HYDROXYPHENYL)ETHANOL; ZINC00164581; SB 01196; 4-(2-hydroxyethyl)phenol; InChI=1/C8H10O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,9-10H,5-6H; EINECS 207-930-8; 4-Hydroxyphenylethanol; CHEBI:1879; 501-94-0; 188255_ALDRICH; 79058_FLUKA; C06044; 2-(4-hydroxyphenyl)-ethanol; 4-hydroxyphenethyl alcohol; p-hydroxyphenylethanol; p-hydroxyphenethyl alcohol; 2-(4-hydroxyphenyl)ethanol; p-hydroxyphenylethyl alcohol | C8H10O2 | 138.16 g/mol | C1=CC(=CC=C1CCO)O |
| TCMBANKIN058256 | salidroside | 10338-51-9; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol; SCHEMBL17580247; (2R,3R,4S,5S,6R)-2-[2-(4-hydroxyphenyl)ethoxy]-6-methylol-tetrahydropyran-3,4,5-triol; ACon1_000366; 2-(4-Hydroxyphenyl)ethyl beta-D-glucopyranoside; Glucopyranoside, p-hydroxyphenethyl; Rhodosin; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]tetrahydropyran-3,4,5-triol; MEGxp0_000478; Rhodioloside; beta-D-Glucopyranoside, 2-(4-hydroxyphenyl)ethyl; | C14H20O7 | 300.3 g/mol | C1=CC(=CC=C1CCOC2C(C(C(C(O2)CO)O)O)O)O |
| TCMBANKIN058645 | frehmaglutin D | C9H13ClO4 | C1COC2C3C1C(C(C3(CO2)O)Cl)O | ||
| TCMBANKIN059438 | 2-methoxy-4-propenyl phenol | C10H12O2 | 164.2 g/mol | CC=CC1=CC(=C(C=C1)O)OC | |
| TCMBANKIN059566 | 6-O-E-Feruloylajugol | 524.57 | CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)O | ||
| TCMBANKIN059722 | rehmapicrogenin | C10H16O3 | 184.23 g/mol | CC1=C(C(CCC1O)(C)C)C(=O)O | |
| TCMBANKIN060211 | acteoside | C29H36O15 | 624.6 g/mol | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O | |
| TCMBANKIN060214 | purpureaside b | C35H46O20 | 786.73 | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)COC4C(C(C(C(O4)CO)O)O)O)OCCC5=CC(=C(C=C5)O)O)O)O)O)O | |
| TCMBANKIN061276 | deacyl-martynoside | C21H32O12 | 476.47 g/mol | CCOC1C(C(C(C(O1)CO)O)OC2C(C(C(C(O2)C)O)O)O)(C3=CC(=C(C=C3)OC)O)O | |
| TCMBANKIN061413 | GBGB | Cyclopenta(c)pyran-4-carboxylic acid, 1-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-1,4a,5,7a-tetrahydro-7-(hydroxymethyl)-, methyl ester, (1R-(1alpha,4aalpha,7aalpha))-; Genipin 1-gentiobioside; (1S,4aS,7aS)-7-methylol-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[d]pyran-4-carboxylic acid methyl ester; methyl (1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[d]pyran-4-carboxylate; Genipin 1-beta-gentiobioside; 29307-60-6; methyl (1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[d]pyran-4-carboxylate; (1S,4aS,7aS)-7-(hydroxymethyl)-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-1,4a,5,7a-tetrahydrocyclopenta[d]pyran-4-carboxylic acid methyl ester;genipin-gentiobioside;genipingentiobioside;genipin- 1- O- β- D- gentiobioside | C23H34O15 | 550.51g/mol | COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O |
| TCMBANKIN061631 | hydroferulic acid | C10H12O4 | 196.2 g/mol | COC1=C(C=CC(=C1)CCC(=O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab